{"id":107827,"date":"2023-08-23T14:48:05","date_gmt":"2023-08-23T09:18:05","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=107827"},"modified":"2023-08-23T14:48:08","modified_gmt":"2023-08-23T09:18:08","slug":"jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/","title":{"rendered":"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-292569615\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/JBCHEPHARM\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">JB Chemicals &amp; Pharmaceuticals<\/a><\/strong> on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3288574917\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals &amp; Pharmaceuticals said in a regulatory filing.<\/p><p>The company&#8217;s product is the generic version of Pfizer&#8217;s Sinequan capsules which are indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.<\/p><p>The drug will be manufactured at the company&#8217;s formulation manufacturing facility in Panoli, Gujarat, the drug maker noted.<\/p><div class=\"trade-content_5\" id=\"trade-2401820635\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>As per IQVIA MAT data, Doxepin Hydrochloride capsules had an estimated annual sales of USD 23.90 million in the US.<\/p><p>Shares of JB Chemicals were trading 3.86 per cent up at Rs 2,754.90 apiece on the BSE.&nbsp;<\/p><p>J B Mody founded J B Mody Chemicals &amp; Pharmaceuticals in Maharashtra on December 18, 1976, and promoted it at that time as J B Chemicals &amp; Pharmaceuticals (JBC). The company&#8217;s commercial activities include the production and distribution of a wide variety of pharmaceutical formulations, herbal treatments, and APIs.<\/p><div class=\"trade-after-content\" id=\"trade-3529194947\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>JB Chemicals &amp; Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market. The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":49884,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1696,31],"tags":[],"class_list":["post-107827","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-action","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>JB Chemicals receives approval from the USFDA to market generic drugs\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"JB Chemicals &amp; Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0\" \/>\n<meta property=\"og:description\" content=\"JB Chemicals &amp; Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-23T09:18:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-23T09:18:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/\",\"url\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/\",\"name\":\"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"datePublished\":\"2023-08-23T09:18:05+00:00\",\"dateModified\":\"2023-08-23T09:18:08+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"JB Chemicals & Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0 - Trade Brains Features","description":"JB Chemicals & Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/","og_locale":"en_US","og_type":"article","og_title":"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0","og_description":"JB Chemicals & Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.","og_url":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-08-23T09:18:05+00:00","article_modified_time":"2023-08-23T09:18:08+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/","url":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/","name":"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","datePublished":"2023-08-23T09:18:05+00:00","dateModified":"2023-08-23T09:18:08+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"JB Chemicals & Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/jb-chemicals-receives-approval-from-the-usfda-to-market-generic-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"JB Chemicals receives approval from the USFDA to market generic drugs\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=107827"}],"version-history":[{"count":3,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107827\/revisions"}],"predecessor-version":[{"id":107830,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107827\/revisions\/107830"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/49884"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=107827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=107827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=107827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}